Literature DB >> 6209008

Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.

S P Richman, T M Woodcock, T T Kubota, M S Blumenreich, P S Gentile, J C Allegra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6209008

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma.

Authors:  N H Mulder; D T Sleijfer; E G de Vries; H Schraffordt Koops; M J Samson; P H Willemse
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  Phase II study of AMSA alone and in combination with DTIC in patients with metastatic melanoma.

Authors:  A Polyzos; S S Legha; A M Burgess; R S Benjamin; G P Bodey
Journal:  Invest New Drugs       Date:  1988-04       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.